1.0Schreiner Group Forumhttps://forum.schreiner-group.com/en/markus.liedl@schreiner-group.comhttps://forum.schreiner-group.com/en/author/markus-liedlschreiner-group-de/Focus on Drug Protection - Schreiner Group Forumrich600338<blockquote class="wp-embedded-content" data-secret="7pRyPYq71O"><a href="https://forum.schreiner-group.com/en/focus-on-drug-protection/">Focus on Drug Protection</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://forum.schreiner-group.com/en/focus-on-drug-protection/embed/#?secret=7pRyPYq71O" width="600" height="338" title="“Focus on Drug Protection” — Schreiner Group Forum" data-secret="7pRyPYq71O" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://forum.schreiner-group.com/wp-content/uploads/2025/11/schreiner-medipharm-gas-barrier-function-syringes.jpg19201280Biologics, mRNA therapies, antibody drug conjugates (ADCs) as anticancer drugs, and other novel pharmaceuticals are highly effective—but equally sensitive. Reliably protecting them requires more than just suitable primary packaging. At Schreiner MediPharm, Corinna Endres, Product Manager Drug Protection, oversees tailored label solutions with protective functions such as light protection and gas barriers or that are suitable for deep-freeze applications. In an interview, she provides insights into current challenges and innovations in the field of drug protection.